These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6411576)

  • 61. The binding of purified factor VIII/von Willebrand factor to collagens of differing type and form.
    Scott DM; Griffin B; Pepper DS; Barnes MJ
    Thromb Res; 1981 Dec 1-15; 24(5-6):467-72. PubMed ID: 6806932
    [No Abstract]   [Full Text] [Related]  

  • 62. Oral administration of factor VIII concentrate preparation in von Willebrand's disease.
    Sakuragawa N; Niiya K; Kondo S
    Thromb Res; 1985 Jun; 38(6):681-5. PubMed ID: 3927510
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
    Sultan Y; Simeon J; Maisonneuve P; Caen JP
    Thromb Haemost; 1976 Feb; 35(1):110-9. PubMed ID: 1085498
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Selective absence of large forms of factor VIII/von Willebrand factor in acquired von Willebrand's syndrome. Response to transfusion.
    Meyer D; Frommel D; Larrieu MJ; Zimmerman TS
    Blood; 1979 Sep; 54(3):600-6. PubMed ID: 313821
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vitreous, retinal and subretinal hemorrhages associated with von Willebrand's syndrome.
    Shiono T; Abe S; Watabe T; Noro M; Tamai M; Akutsu Y; Ishikawa M; Suzuki S; Mori K
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(5):496-7. PubMed ID: 1521819
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of a simple visual assay of Willebrand factor for diagnosis and carrier identification.
    Reisner HM; Katz HJ; Goldin LR; Barrow ES; Graham JB
    Br J Haematol; 1978 Oct; 40(2):339-50. PubMed ID: 309339
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
    Mannucci PM; Mari D
    Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
    [No Abstract]   [Full Text] [Related]  

  • 68. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
    Johnstone IB; Crane S
    Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Growth hormone (GH) therapy in GH-deficient patients, the plasma factor VIII-von Willebrand factor complex, and capillary fragility. A double-blind, placebo-controlled crossover study.
    Jørgensen JO; Pedersen SA; Ingerslev J; Møller J; Skakkebaek NE; Christiansen JS
    Scand J Clin Lab Invest; 1990 Jun; 50(4):417-20. PubMed ID: 2118272
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of succinylation and dodecyl, succinylation on bovine factor VIII/von Willebrand factor complex.
    Thuy LP; Brown JE; Baugh RF; Hougie C
    Thromb Res; 1980 May 1-15; 18(3-4):305-13. PubMed ID: 6774433
    [No Abstract]   [Full Text] [Related]  

  • 73. Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique.
    Enayat MS; Hill FG
    J Clin Pathol; 1983 Aug; 36(8):915-9. PubMed ID: 6409946
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M; Yasui M; Nishino M; Mikami S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract]   [Full Text] [Related]  

  • 76. The evaluation of factor VIII antigen by means of a simple slide test.
    Casonato A; Fabris F; Vicariotto M; Girolami A
    Am J Clin Pathol; 1985 Jul; 84(1):107-11. PubMed ID: 3925753
    [TBL] [Abstract][Full Text] [Related]  

  • 77. von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy.
    Favaloro EJ; Dean M; Grispo L; Exner T; Koutts J
    Am J Hematol; 1994 Mar; 45(3):205-11. PubMed ID: 8296790
    [TBL] [Abstract][Full Text] [Related]  

  • 78. VIIIR; Ag in platelets from patients with various forms of von Willebrand's disease.
    Holmbeg L; Nilsson IM
    Thromb Haemost; 1979 Oct; 42(3):1033-8. PubMed ID: 388718
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
    Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
    Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.